NO983945L - Isokinoliner som er nyttige som analgetika - Google Patents

Isokinoliner som er nyttige som analgetika

Info

Publication number
NO983945L
NO983945L NO983945A NO983945A NO983945L NO 983945 L NO983945 L NO 983945L NO 983945 A NO983945 A NO 983945A NO 983945 A NO983945 A NO 983945A NO 983945 L NO983945 L NO 983945L
Authority
NO
Norway
Prior art keywords
analgesics
isoquinolines
useful
compounds
isoquinolines useful
Prior art date
Application number
NO983945A
Other languages
English (en)
Norwegian (no)
Other versions
NO983945D0 (no
Inventor
John Dimaio
Wuyi Wang
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO983945D0 publication Critical patent/NO983945D0/no
Publication of NO983945L publication Critical patent/NO983945L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO983945A 1996-02-28 1998-08-27 Isokinoliner som er nyttige som analgetika NO983945L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9600769A SE9600769D0 (sv) 1996-02-28 1996-02-28 Compounds useful as analgesic
PCT/SE1997/000315 WO1997031940A1 (en) 1996-02-28 1997-02-25 Isoquinolines useful as analgesics

Publications (2)

Publication Number Publication Date
NO983945D0 NO983945D0 (no) 1998-08-27
NO983945L true NO983945L (no) 1998-10-06

Family

ID=20401594

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983945A NO983945L (no) 1996-02-28 1998-08-27 Isokinoliner som er nyttige som analgetika

Country Status (20)

Country Link
US (1) US6034097A (cs)
EP (1) EP0914332B1 (cs)
JP (1) JP2000506138A (cs)
KR (1) KR19990087322A (cs)
CN (1) CN1211990A (cs)
AT (1) ATE217322T1 (cs)
AU (1) AU722032B2 (cs)
BR (1) BR9707767A (cs)
CA (1) CA2244219A1 (cs)
CZ (1) CZ272098A3 (cs)
DE (1) DE69712490D1 (cs)
EE (1) EE9800266A (cs)
IL (1) IL125925A0 (cs)
IS (1) IS4834A (cs)
NO (1) NO983945L (cs)
NZ (1) NZ331119A (cs)
PL (1) PL328734A1 (cs)
SE (1) SE9600769D0 (cs)
SK (1) SK113498A3 (cs)
WO (1) WO1997031940A1 (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604789D0 (sv) * 1996-12-20 1996-12-20 Astra Ab New Compounds
JP4565747B2 (ja) * 1999-02-04 2010-10-20 エスケー ホルディングス カンパニー リミテッド テトラヒドロイソキノリンアルカノール誘導体及びそれを含む薬学的組成物
IL144583A0 (en) * 2001-07-26 2002-05-23 Peptor Ltd Chimeric protein kinase inhibitors
JP4459629B2 (ja) 2002-04-12 2010-04-28 メルク エンド カムパニー インコーポレーテッド 二環式アミド
IL156429A0 (en) * 2003-06-12 2004-01-04 Peptor Ltd Cell permeable conjugates of peptides for inhibition of protein kinases
CN100503571C (zh) 2006-07-12 2009-06-24 中国药科大学 四氢异喹啉类衍生物、其制备方法及其医药用途
WO2008016913A1 (en) * 2006-07-31 2008-02-07 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Biologically potent analogues of the dmt-tic pharmacophore and methods of use
US9623021B2 (en) 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
CA2676066C (en) 2007-01-22 2016-06-28 Gtx, Inc. Nuclear receptor binding agents
WO2011104649A1 (en) 2010-02-25 2011-09-01 Pfizer Limited Peptide analogues
WO2014100695A1 (en) 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors and uses thereof
PT2935222T (pt) 2012-12-21 2018-12-10 Epizyme Inc Inibidores de prmt5 e seus usos
JP2016505597A (ja) 2012-12-21 2016-02-25 エピザイム,インコーポレイティド Prmt5阻害剤およびその使用
US9745291B2 (en) 2012-12-21 2017-08-29 Epizyme, Inc. PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
JP2016505001A (ja) 2012-12-21 2016-02-18 エピザイム,インコーポレイティド Prmt5阻害剤およびその使用
CN103450079B (zh) * 2013-08-14 2015-07-29 中国药科大学 四氢异喹啉羟基衍生物、其制备方法及其医药用途
AU2015301196A1 (en) 2014-08-04 2017-01-12 Epizyme, Inc. PRMT5 inhibitors and uses thereof
EP3565543A4 (en) * 2017-01-06 2020-10-14 The Regents of The University of California MU TYPE OPIOID RECEIVER MODULATORS
WO2019195634A1 (en) 2018-04-04 2019-10-10 Epiodyne, Inc. Opioid receptor modulators and products and methods related thereto
TW202304869A (zh) 2021-04-05 2023-02-01 美商艾碧奧戴股份有限公司 類鴉片受體調節劑
CN115260096B (zh) * 2022-08-19 2024-04-09 武汉大学 一种基于一氧化碳气体或一氧化碳替代源合成二氢异喹啉酮类化合物的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599325A (en) * 1984-02-16 1986-07-08 G. D. Searle & Co. Substituted tyrosyl alanine dipeptide amides
US5648333A (en) * 1988-11-24 1997-07-15 Hoechst Aktiengesellschaft Peptides having bradykinin antagonist action
SE9300012D0 (sv) * 1993-01-05 1993-01-05 Astra Ab New peptides
CA2090171A1 (en) * 1993-02-23 1994-08-24 Peter W. Schiller Opioid receptor antagonists, their synthesis and use as analgesic and immunosuppressive compounds
CA2118985A1 (en) * 1993-04-02 1994-10-03 Dinesh V. Patel Heterocyclic inhibitors of farnesyl protein transferase
SE9402880D0 (sv) * 1994-08-30 1994-08-30 Astra Ab New peptide derivatives

Also Published As

Publication number Publication date
SK113498A3 (en) 1999-02-11
CZ272098A3 (cs) 1999-03-17
JP2000506138A (ja) 2000-05-23
BR9707767A (pt) 1999-07-27
AU2109097A (en) 1997-09-16
DE69712490D1 (de) 2002-06-13
IS4834A (is) 1998-08-26
AU722032B2 (en) 2000-07-20
CA2244219A1 (en) 1997-09-04
SE9600769D0 (sv) 1996-02-28
EP0914332A1 (en) 1999-05-12
EP0914332B1 (en) 2002-05-08
US6034097A (en) 2000-03-07
CN1211990A (zh) 1999-03-24
NO983945D0 (no) 1998-08-27
PL328734A1 (en) 1999-02-15
KR19990087322A (ko) 1999-12-27
NZ331119A (en) 2000-05-26
IL125925A0 (en) 1999-04-11
EE9800266A (et) 1999-02-15
ATE217322T1 (de) 2002-05-15
WO1997031940A1 (en) 1997-09-04

Similar Documents

Publication Publication Date Title
NO983945L (no) Isokinoliner som er nyttige som analgetika
ATE215369T1 (de) Carbazolanaloge als selektive beta3-adrenergische agonisten
NO20013149L (no) Piperidiner som CCR5-modulatorer
DK1114032T3 (da) 4-aminosubstituerede-2-substituerede-1,2,3,4-tetrahydroquinoliner som CETB-inhibitorer
DZ2268A1 (fr) Pyridines substituées comme inhibiteurs sélectifs de 2-cycloxygènase.
NO20013864L (no) Brenselsblanding
DK1001752T3 (da) Analgetiske fremgangsmåder under anvendelse af syntetiske katalysatorer til dismutation af superoxidradikaler
ATE297898T1 (de) 4-carboxamino-2-subsitutierte-1,2,3,4- tetrahydrochinoline als cetp inhibitoren
ATE277906T1 (de) 4-carboxamino-2-methyl-1,2,3,4- tetrahydrochinoline als cetp inhibitoren
DK1019507T3 (da) Aminoterminalt afkortede RANTES som kemokinantagonister
DE60043051D1 (de) Dafür kodierende polynukleotide. verwendungen
NL1016362A1 (nl) Vlamvertragende polyolefineharssamenstelling, werkwijze voor de bereiding daarvan en vlamvertragende kabels.
DK0871623T3 (da) 3-Azetinidylalkylpiperidiner eller -pyrrolidiner som tachykininantagonister
MXPA03004652A (es) Derivados de piperidina como antagonistas selectivos de subtipo de n-metil-d-aspartato.
BR0007922A (pt) Compostos calcilìticos
ZA200201789B (en) Substituted pyrrolidin-2,3,4-trion-3-oxime drivatives useful as NMDA-receptor antagonists.
DE69916191D1 (de) Fahrbares Gerät zum Mischen von Futter
DE60026350D1 (de) Diaryl piperidyl-pyrrol-derivate als antiprotozoenmittel
IT1311999B1 (it) Miscela liquida adatta come benzina.
NO20010400L (no) Isokinoliner som urokinaseinhibitorer
TW200501726A (en) Techniques to perform line qualification
DE29810464U1 (de) Vorrichtung zum Sägen von Kaminholz o.dgl.
ES1047917Y (es) Tapon perfeccionado de corcho.
IT244724Y1 (it) Dispositivo per infissi .
IT1288132B1 (it) Sonda intraoperatoria, in particolare per le osservazioni per contatto diretto.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application